Mathematical modelling of enfuvirtide and protease inhibitors as combination therapy for HIV
From MaRDI portal
(Redirected from Publication:1661641)
Recommendations
- Impact of combined therapy in HIV-1 treatment: a double impulsive approach
- Modelling the effects of adherence to the HIV fusion inhibitor enfuvirtide
- Modelling two different therapy strategies for drug T-20 on HIV-1 patients
- Mechanism-based model of the pharmacokinetics of enfuvirtide, an HIV fusion inhibitor
- Modelling the immunopathogenesis of HIV-1 infection and the effect of multidrug therapy: the role of fusion inhibitors in HAART
Cites work
- scientific article; zbMATH DE number 4097853 (Why is no real title available?)
- scientific article; zbMATH DE number 732332 (Why is no real title available?)
- scientific article; zbMATH DE number 2038872 (Why is no real title available?)
- scientific article; zbMATH DE number 798146 (Why is no real title available?)
- A New Mathematical Model for Assessing Therapeutic Strategies for HIV Infection
- A mathematical model on ctl mediated control of HIV infection in a long-term drug therapy
- A model for control of HIV/AIDS with parental care
- Anti-viral drug treatment along with immune activator IL-2: a control-based mathematical approach for HIV infection
- CTL response suppression in chronic phase of infection: a mathematical study
- Can the viral reservoir of latently infected \(CD4^{+}\) T cells be eradicated with antiretroviral HIV drugs?
- Distinct effects of protease and reverse transcriptase inhibition in an immunological model of HIV-1 infection with impulsive drug effects
- Drug concentration heterogeneity facilitates the evolution of drug resistance
- Drug resistance in an immunological model of HIV-1 infection with impulsive drug effects
- Explicitly accounting for antiretroviral drug uptake in theoretical HIV models predicts long-term failure of protease-only therapy
- Mathematical Analysis of HIV-1 Dynamics in Vivo
- Modelling the effects of adherence to the HIV fusion inhibitor enfuvirtide
- Modelling two different therapy strategies for drug T-20 on HIV-1 patients
- Saturation effects for CTL mediated control of HIV-1 infection: a mathematical study
- The failure of \(R_{0}\)
Cited in
(12)- Modelling two different therapy strategies for drug T-20 on HIV-1 patients
- Two-way Bayesian hierarchical phylogenetic models: an application to the co-evolution of gp120 and gp41 during and after enfuvirtide treatment
- Analysis of HIV latent infection model with multiple infection stages and different drug classes
- MODELING MONOCYTE-DERIVED DENDRITIC CELLS AS A THERAPEUTIC VACCINE AGAINST HIV
- Role of antibiotic therapy in bacterial disease: a mathematical study
- Mathematical modeling for the prevention of methanol poisoning through ethanol by impulsive way
- Impact of combined therapy in HIV-1 treatment: a double impulsive approach
- Mechanism-based model of the pharmacokinetics of enfuvirtide, an HIV fusion inhibitor
- The impact of vaccination to control human papillomavirus dynamics
- Modelling the effects of adherence to the HIV fusion inhibitor enfuvirtide
- How can HPV-induced cervical cancer be controlled by a combination of drug therapy? A mathematical study
- Impact of Tenofovir gel as a PrEP on HIV infection: a mathematical model
This page was built for publication: Mathematical modelling of enfuvirtide and protease inhibitors as combination therapy for HIV
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q1661641)
